QDEL
QuidelOrtho Corp
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$10.62
−4.24%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$10.99
From 52W high−69.98%
Volume2.96M
Market cap$728.27M
P/E (TTM)—
P/S (TTM)0.3x
Div yield—
Key dataSep 18, 2026
Open
$10.99
From 52W high
−69.98%
Volume
2.96M
Market cap
$728.27M
ValuationView details →
P/E (Fwd)
12.3x
EV/EBITDA
−7.4x
P/E (TTM)
—
RSI (14)
29.8
MomentumView details →
1D Return
−4.24%
YTD Return
−62.34%
SummaryUpdated Jun 1, 2026
QuidelOrtho Corporation (NASDAQ:QDEL) is a leading diagnostic testing company formed through the 2022 merger of Quidel Corporation and Ortho Clinical Diagnostics. Founded originally as Quidel in 1979, the company has evolved into a comprehensive diagnostics provider serving healthcare facilities worldwide. The company went public in 1991 and is headquartered in San Diego, California. QuidelOrtho operates across the full spectrum of diagnostic testing, from point-of-care rapid tests to sophisticated laboratory instruments, serving hospitals, clinical laboratories, blood banks, and physician offices globally.
Similar companies
Latest newsMore news →
QuidelOrtho cut its 2026 outlook, citing deeper China and respiratory risks, while cash use and rising debt add pressure despite resilient core growth.34d agoQuidelOrtho Corporation reported second quarter 2026 financial results with total revenue of $631 million, up 3% as reported and 2% in constant currency, driven by Labs and Point of Care growth.45d agoQuidelOrtho plans to sell its testing unit for $1.5 billion.85d ago